Evidence-Based Information and Analysis
Pernicious anemia is a demyelinating neurological disease. Vitamin B12 malabsorption leads to central and peripheral nerve damage, neurological and psychiatric symptoms that often precede anemia, and recovery limits set by the biology of myelin repair rather than blood test normalization.
Leaky gut—increased intestinal permeability—reflects failure at the gut barrier. Progress comes from reducing ongoing injury, restoring barrier structure, and correcting upstream drivers that keep reopening it. Supplements matter less than sequencing and consistency.
**> Gastric hydrochloric acid is a master regulator of digestion, coordinating timing, antimicrobial defense, bile and enzyme signaling, mineral absorption, and immune exposure; protein digestion is only one visible endpoint of a much larger control system.
Dimethyl sulfoxide (DMSO) alters herbal preparations by changing extraction breadth, absorption pathways, and systemic exposure. These changes matter more than the identity of the solvent itself.
→ DMSO removes constraints that normally limit how much of a plant’s chemistry reaches the body.
*This document represents an initial phase of structured research into DMSO as a menstruum for herbal extraction. It records mechanisms, evidence, and screening logic as they currently stand. It is not a recommendation in any way, and safety issues are not fully developed.
The research trajectory indicates two parallel outcomes:
Dragon’s Blood and latex sealants deliver rapid, reliable wound protection in herbal practice through their unique film-forming action. These exudates ooze thickly, coagulate on contact, and form adherent barriers that seal cuts and staunch bleeding locally. Unlike diffusing resins, they prioritize immediate containment, guided by tactile feedback.
Pernicious anemia is often described as a rare autoimmune disease that causes vitamin B12 deficiency and anemia. That description is technically incomplete and historically misleading. The modern failures in diagnosis and treatment of pernicious anemia are not primarily due to lack of evidence or lack of effective therapy. They are the result of a long chain of observational bias, naming inertia, disciplinary silos, and systemic blind spots in medical education—particularly around nutrition and chronic disease.
To understand why pernicious anemia remains underdiagnosed and inadequately treated today, it is necessary to understand how the disease was first observed, how it was defined, and how those early definitions hardened into doctrine even as evidence changed.
Pernicious anemia shares symptoms with many other conditions and cannot be diagnosed in isolation. This guide explains what else must be ruled out, how symptoms overlap, and when PA should remain on the diagnostic table.
Pernicious anemia (PA) has strong genetic and autoimmune components. Family history significantly increases risk, and testing may be appropriate even without obvious symptoms.
Many people with PA report years of symptoms before diagnosis, often because family risk was not recognized or discussed. Understanding risk patterns helps identify who should be tested earlier—before permanent neurological damage occurs.
—
A systematic approach to testing is most useful for getting an accurate diagnosis. This checklist lays out which tests to request, how to review results, and how to avoid delays caused by inadequate or piecemeal testing.
| Title | Price | Purpose | Condition | Build Date |
|---|